{"id":49390,"date":"2022-10-07T17:01:58","date_gmt":"2022-10-07T15:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-autosomal-dominant-polycystic-kidney-disease-epidemiology-forecast-report-to-2032-researchandmarkets-com\/"},"modified":"2022-10-07T17:01:58","modified_gmt":"2022-10-07T15:01:58","slug":"global-autosomal-dominant-polycystic-kidney-disease-epidemiology-forecast-report-to-2032-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-autosomal-dominant-polycystic-kidney-disease-epidemiology-forecast-report-to-2032-researchandmarkets-com\/","title":{"rendered":"Global Autosomal Dominant Polycystic Kidney Disease Epidemiology Forecast Report to 2032 – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Autosomal Dominant Polycystic Kidney Disease – Epidemiology Forecast – 2032”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThis report delivers an in-depth understanding of Autosomal Dominant Polycystic Kidney Disease, historical and forecasted epidemiology as well as Autosomal Dominant Polycystic Kidney Disease trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.\n<\/p>\n

\nAutosomal Dominant Polycystic Kidney Disease Understanding<\/strong>\n<\/p>\n

\nAutosomal dominant polycystic kidney disease, also called “adult PKD” is the most common inherited kidney disorder characterized by the growth of cysts in the kidneys, which eventually leads to kidney failure. A monogenetic disorder, Autosomal Dominant Polycystic Kidney Disease is caused by mutations in either the PKD1 gene found on chromosome 16 or the PKD2 gene found on chromosome 4. Mutations in PKD1 are more common and account for about 85% of all Autosomal Dominant Polycystic Kidney Disease cases.\n<\/p>\n

\nAutosomal Dominant Polycystic Kidney Disease is characterized by bilateral renal cysts, kidney pain, frequent urinary tract infection, hematuria, nephrolithiasis, hypertension, and progressive renal failure due to progressive enlargement of cysts and fibrosis. It is one of the leading causes of renal replacement and end-stage renal disease.\n<\/p>\n

\nAside from renal cysts, patients frequently have extra renal diseases, which consist of cysts in the liver, seminal vesicle, pancreas, arachnoid membrane, and connective tissue abnormalities like mitral valve prolapse, intracranial aneurysms, diverticular disease, and abdominal hernia; hypertension and left ventricular hypertrophy, and hypertension and left ventricular hypertrophy. Other cardiovascular abnormalities include aortic and arachnoid aneurysms. Recognition of these extra renal manifestations (ERM) reduces diagnostic uncertainty and majorly influences the treatment administered.\n<\/p>\n

\nAutosomal Dominant Polycystic Kidney Disease Detailed Epidemiology Segmentation<\/strong>\n<\/p>\n